The listing of THG Beauty reflects a period of strong organic growth and growing US footprint for the department.
The decision to list THG Beauty comes after an announcement in May that the group was undertaking a corporate structure review, enabling the firm to complete SBM’s investment into its Ingenuity platform for a 19.9% stake.
While the commercial details of the listing are yet to be disclosed until H1 FY22, the group also claimed that it is considering a separate float for THG Nutrition.
THG Beauty’s listing announcement came as THG reported H1 FY21 revenues of £958.8m, up 41.9% year-on-year.
Adjusted EBITDA at the firm also climbed 38.6% year-on-year to £81.2m in the half-year ended 30 June 2021.
Matthew Moulding, executive chairman and CEO at THG, said: “I am delighted to announce a strong first half performance across all divisions, as we continue to invest significantly in support of our strategic growth ambitions.”
THG Beauty achieved a 55.9% year-on-year revenue growth to £460.8m in FY21, with Moulding adding that the listing will “create further value” for the company’s shareholders.